Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00028083
DRKS00028083
Recruiting
N/A

Contrast-enhanced ultrasound (CEUS) to assess perfusion in suspected joint infection after arthroplasty joint replacement - CEUS, infection, arthroplasty

Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie0 sites100 target enrollmentFebruary 14, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsT84.0Mechanical complication of internal joint prosthesis

Overview

Phase
N/A
Intervention
Not specified
Conditions
T84.0
Sponsor
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie

Eligibility Criteria

Inclusion Criteria

  • •Adult patients with suspected joint infection in the hip or knee joint after total joint replacement who present and are examined at Heidelberg University Hospital are included in the study. In addition, patients who return 1 year postoperatively (or later) for routine follow\-up after joint replacement are invited to participate in the study.

Exclusion Criteria

  • •\- Age under 18 years
  • •\- Inability to consent
  • •\- Known intolerance to SonoVue® or other ultrasound contrast media.
  • •\- Allergic reaction when given SonoVue®
  • •\- Patients with known right\-to\-left shunt, severe pulmonary hypertension (pulmonary artery pressure \> 90 mmHg), uncontrolled systemic hypertension or acute respiratory distress syndrome
  • •\- Pregnancy and breast feeding period.
  • •\- Lack of informed consent or
  • •\- refusal to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumorsD48.9Neoplasm of uncertain or unknown behaviour, unspecified
DRKS00028080Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie300
Completed
N/A
Contrast-enhanced Ultrasound (CEUS) for determining muscular Perfusion after oral intake of L-Citrulline, L-Arginine, and galloylated epicatechines.Examination of different sport supplement ingredients for their potency of vasodilation in skeletal muscle.
DRKS00016972niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie30
Recruiting
N/A
Quantification of Contrast Enhanced Ultrasound (CEUS) in the detection of Prostate cancer.Prostate adenocarcinomaProstate cancer10038364
NL-OMON36092Academisch Medisch Centrum560
Recruiting
N/A
sefulness of contrast-enhanced ultrasound (CEUS) in Crohn’s disease pediatric patientsDiseases of the digestive system
KCT0005685Yonsei University Health System, Severance Hospital20
Active, Not Recruiting
Phase 1
Study of placental vascularization using contrast ultrasoundFetal growth restrictionMedDRA version: 20.0Level: PTClassification code: 10070531Term: Foetal growth restriction Class: 100000004868Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
CTIS2023-506936-34-00CHRU De Nancy30